These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28117282)

  • 1. Modified residual SYNTAX score and clinical outcomes in patients with multivessel disease undergoing percutaneous coronary intervention.
    Park TK; Hahn JY; Yang JH; Song YB; Choi SH; Choi JH; Lee SH; Ahn J; Carriere KC; Gwon HC
    EuroIntervention; 2017 May; 13(1):87-96. PubMed ID: 28117282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of residual SYNTAX score on clinical outcomes after incomplete revascularisation percutaneous coronary intervention: a large single-centre study.
    Song Y; Gao Z; Tang X; Jiang P; Xu J; Yao Y; Li J; Zhao X; Qiao S; Yang Y; Gao R; Xu B; Yuan J
    EuroIntervention; 2017 Nov; 13(10):1185-1193. PubMed ID: 28760723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of "complete, partially complete, and incomplete" revascularisation at five-year follow-up after percutaneous intervention of unprotected left main coronary artery disease with drug-eluting stents.
    Zhang YJ; Iqbal J; Xu B; Ye F; Zhang JJ; Bourantas CV; Pan DR; Tian NL; Kan J; Qian XS; Ding SQ; Li F; Zhang AP; Liu YQ; Muramatsu T; Onuma Y; Garcia-Garcia HM; Serruys PW; Chen SL
    EuroIntervention; 2016 Oct; 12(8):e957-e963. PubMed ID: 26690316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index.
    Généreux P; Campos CM; Yadav M; Palmerini T; Caixeta A; Xu K; Francese DP; Dangas GD; Mehran R; Leon MB; Serruys PW; Stone GW
    EuroIntervention; 2015 Oct; 11(6):634-42. PubMed ID: 25308300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of residual coronary lesions on clinical outcomes after percutaneous coronary intervention: Residual SYNTAX score after percutaneous coronary intervention in patients from the Efficacy of Xience/Promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) registry.
    Park KW; Kang J; Kang SH; Ahn HS; Kang HJ; Koo BK; Chae IH; Youn TJ; Oh BH; Park YB; Kandzari D; Kim HS
    Am Heart J; 2014 Mar; 167(3):384-392.e5. PubMed ID: 24576524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery.
    Cavalcante R; Sotomi Y; Zeng Y; Lee CW; Ahn JM; Collet C; Tenekecioglu E; Suwannasom P; Onuma Y; Park SJ; Serruys PW
    Heart; 2017 Mar; 103(6):428-433. PubMed ID: 27651390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incremental impact of residual SYNTAX score on long-term clinical outcomes in patients with multivessel coronary artery disease treated by percutaneous coronary interventions.
    Witberg G; Lavi I; Assali A; Vaknin-Assa H; Lev E; Kornowski R
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):3-10. PubMed ID: 25413668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of residual SYNTAX score with second-generation drug-eluting stents: one-year results from the prospective multicentre SEEDS study.
    Xu B; Yang YJ; Han YL; Lu SZ; Li B; Liu Q; Zhu GY; Cui JY; Li L; Zhao YL; Kirtane AJ;
    EuroIntervention; 2014 May; 10(1):65-73. PubMed ID: 24603020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents.
    Chang M; Ahn JM; Kim N; Lee PH; Roh JH; Yoon SH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    Am Heart J; 2016 Sep; 179():157-65. PubMed ID: 27595691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease: A Patient-Level Pooled Analysis of 6,081 Patients.
    Piccolo R; Pilgrim T; Heg D; Franzone A; Rat-Wirtzler J; Räber L; Silber S; Serruys PW; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1657-66. PubMed ID: 26585615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of residual SYNTAX score after percutaneous coronary intervention in patients with chronic total occlusion and multivessel coronary artery disease: a comparison with coronary artery bypass grafting.
    Jang WJ; Yang JH; Song YB; Hahn JY; Choi JH; Chun WJ; Oh JH; Park YH; Kim WS; Lee YT; Gwon HC; Choi SH
    EuroIntervention; 2017 May; 13(1):97-105. PubMed ID: 28242583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple arterial grafting confers survival advantage compared to percutaneous intervention with drug-eluting stents in multivessel coronary artery disease: A propensity score adjusted analysis.
    Raja SG; Benedetto U; Ilsley CD; Amrani M;
    Int J Cardiol; 2015; 189():153-8. PubMed ID: 25897895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score.
    Farooq V; Serruys PW; Bourantas CV; Zhang Y; Muramatsu T; Feldman T; Holmes DR; Mack M; Morice MC; Ståhle E; Colombo A; de Vries T; Morel MA; Dawkins KD; Kappetein AP; Mohr FW
    Circulation; 2013 Jul; 128(2):141-51. PubMed ID: 23766350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proximal left anterior descending coronary artery stenosis should be considered when using the prognostic value of the residual SYNTAX score: Data from 10343 consecutive patients with long-term follow up in the real world.
    Gao G; Feng L; Zhang D; Song C; Zhu C; Song W; Zhao Y; Xu B; Yin D; Dou K
    Catheter Cardiovasc Interv; 2018 Feb; 91(S1):639-645. PubMed ID: 29542281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention.
    Capodanno D; Chisari A; Giacoppo D; Bonura S; Lavanco V; Capranzano P; Caggegi A; Ministeri M; Tamburino C
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):333-40. PubMed ID: 22936604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the residual SYNTAX score on clinical outcomes after percutaneous coronary intervention for patients with chronic renal insufficiency.
    Yan L; Li P; Wang Y; Han D; Li S; Zhang J; Jiang M; Fan L; Han Y; Cao F
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1(Suppl 1):606-615. PubMed ID: 31868307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.